Form 4: SenesTech CEO Michael Edell Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
SenesTech CEO Michael Edell was granted 263,288 stock options with an exercise price of $1.47 per share.
Summary
- CEO Michael Edell received a grant of 263,288 stock options on June 9, 2026.
- The options have an exercise price of $1.47 per share.
- The options vest in one-twelfth increments quarterly, starting June 30, 2026, with full vesting by March 31, 2029.
- The options expire on May 6, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that does not signal a change in company fundamentals.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future shareholder dilution upon the exercise of these options.
Risks
- Vesting is contingent upon the availability of shares under the current stockholder-approved share reserve (EIP Reserve).
- If the EIP Reserve is insufficient, exercisability of the options is delayed until further stockholder approval is obtained.
Future Outlook
The options are scheduled to vest quarterly over a three-year period, concluding on March 31, 2029, provided the executive maintains continuous service.
Industry Context
StockSavvy.ai notes that equity grants for executive leadership are standard practice in the biotechnology and pest control sectors to incentivize long-term performance and retention.
Comparison to Industry Standards
- The use of multi-year vesting schedules is consistent with standard corporate governance practices for executive compensation.
- The inclusion of a contingency clause regarding share reserve availability is a common protective measure in equity incentive plans.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Contingency | Options are subject to the availability of shares under the stockholder-approved EIP Reserve. | 06/09/2026 | Ensures compliance with shareholder-approved share limits. |
Stakeholder Impact
- Shareholders may experience minor dilution if options are exercised in the future.
Next Steps
- Quarterly vesting of options beginning June 30, 2026.
- Potential requirement for future stockholder approval if the EIP Reserve is insufficient for full exercise.
Key Dates
| Date | Description |
|---|---|
| 06/09/2026 | Date of the stock option grant transaction. |
| 06/30/2026 | First vesting date for the granted options. |
| 05/06/2036 | Expiration date of the stock options. |
Keywords
SenesTech, SNES, Form 4, Executive Compensation, Stock Options, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.